KRT18 and infection: Our studies in K18-hACE2 mice provide evidence that ipsilateral and contralateral boosting with mRNA vaccines elicit comparable immune responses, and this was associated with equivalent control of infection by a SARS-CoV-2 Omicron challenge strain.